(firstQuint)The Bladder Instillation Comparison Study.

 This study will compare standard of care treatment for patients with non-muscle invasive bladder cancer (NMIBC).

 Patients will be randomized to one of three arms, Mitomycin C, Gemcitabine or no additional treatment immediately following TURBT in the operating suite.

 All treatment, surgical procedures and follow up care will be conducted according to standard of care treatment.

.

 The Bladder Instillation Comparison Study@highlight

To compare the efficacy of Mitomycin C vs.

 Gemcitabine vs.

 no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.

